Valirx - About the company
Valirx is a public company based in London (United Kingdom), founded in 2000. It operates as a Developer of novel technologies and products in oncology therapeutics and diagnostics. Valirx has raised an undisclosed amount in funding. The company has 218 active competitors, including 74 funded and 36 that have exited. Its top competitors include companies like Seer, GRAIL and Tango Therapeutics.
Company Details
Developer of novel technologies and products in oncology therapeutics and diagnostics. Its lead programs include VAL201 for the treatment of prostate cancer and VAL401 for lung cancer. Its other proprietaries include GeneICE (VAL101), a technology that enables selective silencing of the rebellion, preventing the activity from the rebellious gene; GeneICE – Bcl-2, a new therapeutic drug that targets and switch off the gene that expresses Bcl-2 and NAV3 cancer screening test that indicates the onset of malignancy or tumour formation.
- Website
- www.valirx.com
- Email ID
- *****@valirx.com
Key Metrics
Founded Year
2000
Location
London, United Kingdom
Stage
Public
Latest Funding Round
Ranked
17th among 218 active competitors
Employee Count
13 as on May 31, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Valirx
Valirx is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Valirx Plc CIN: 3916791 , Germany, Active | Jan 25, 2000 | - | 7 (As on Dec 31, 2021) |
Valirx's IPO details
Valirx got listed on Oct 03, 2006.
Click here to take a look at Valirx's IPO in detail
Sign up to download Valirx's company profile
Valirx's funding and investors
Valirx has raised funding over 11 rounds. Its first funding round was on Dec 27, 2013.
Here is the list of recent funding rounds of Valirx:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 13, 2019 | 3045180 | Post IPO | 7382886 | 5600402 | 1579567 | 7622049 |
Dec 18, 2018 | 6610963 | Post IPO | 1209027 | 6362672 | 2416074 | 5581253 |
Dec 2018 | 4806959 | Post IPO | 2950731 | 4770383 | 3868226 | 3697674 |
Access funding benchmarks and valuations. Sign up today!View details of Valirx's funding rounds and investors
Valirx's founders and board of directors
Founder? Claim ProfileValirx's employee count trend
Valirx has 13 employees as of May 26. Here is Valirx's employee count trend over the years:
Uncover Valirx's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Valirx's Competitors and alternates
Top competitors of Valirx include Seer, GRAIL and Tango Therapeutics. Here is the list of Top 10 competitors of Valirx, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Seer 2017, San Francisco (United States), Public | Developer of proteomics platform for early detection of cancer and neurological diseases | $128M | 72/100 | |
2nd |  GRAIL 2016, Menlo Park (United States), Public | Developer of a screening platform for circulating tumor DNA to detect cancer | $2B | 71/100 | |
3rd |  Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | 71/100 | |
4th | Developer of non-invasive blood-based diagnostics for cancer | $105M | 67/100 | ||
5th | Maze Therapeutics 2018, Redwood City (United States), Public | Developer of genetic bio-markers in neurological, metabolic, and renal diseases | $496M | 66/100 | |
6th | Metabolon 2000, Morrisville (United States), Series H | Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine | $166M | 66/100 | |
7th | Lexicon Pharmaceuticals 1995, The Woodlands (United States), Public | Developer of small molecule drugs for diffrent health diseases | - | 64/100 | |
8th | NeoGenomics 2002, Fort Myers (United States), Public | Provider of cancer genetic diagnostic services | - | 63/100 | |
9th |  Wobble Genomics 2020, Edinburgh (United Kingdom), Series A | Provider of a platform for discovery of nucleic acid biomarkers | $12.5M | 62/100 | |
10th | Developer of cancer diagnostic tests | - | 61/100 | ||
17th | Valirx 2000, London (United Kingdom), Public | Developer of novel technologies and products in oncology therapeutics and diagnostics | - | - | 53/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Valirx's competitors? Click here to see the top ones
Valirx's Investments and acquisitions
Valirx has a total of 1 investment in TuHURA Biosciences. Valirx has not made any acquisitions as of now.Reports related to Valirx
Here is the latest report on Valirx's geography:
News related to Valirx
Filter this listMedia has covered Valirx for a total of 5 events in the last 1 year, 3 of them have been about company updates.
•
•
EARNINGS: ValiRx says trading "challenging"; Mindflair swings to lossShareprices•Sep 29, 2025•Valirx
•
•
ValiRx Establishes New Subsidiary Blue Ribbon Bio for Prostate Cancer AssetsShareprices•Aug 26, 2025•Valirx
•
ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing dealShareprices•Aug 04, 2025•Dominion Biotech, Valirx
•
ValiRx signs licence with Ambrose worth GBP16 million plus royaltiesMorningstar•Jun 20, 2025•Ambrose Healthcare, Valirx
•
•
•
•
ValiRx shares fall as ends collaboration with Imperial College LondonMorningstar•Feb 24, 2025•Valirx, Imperial College London
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Valirx
Explore our recently published companies
- Autocal - Thane based, 2002 founded, Funding Raised company
- Indo Amines - Thane based, 1994 founded, Public company
- Taro International - Haifa based, 1992 founded, Unfunded company
- SmartCart AI - San Francisco based, Unfunded company
- 365 Retail Markets - London based, 2008 founded, Unfunded company
- Bishop Paiute Development Corporation - Bishop based, 2009 founded, Funding Raised company
